Third National Registry of Cardiac Rehabilitation Programs in Mexico (RENAPREC III-2022) / Tercer Registro Nacional de Programas de Rehabilitación Cardiaca en México (RENAPREC III-2022)

Abstract Introduction: In Mexico, cardiac rehabilitation (CR) as an interdisciplinary intervention with therapeutic impact in patients with heart disease is growing. There is the need to know actual conditions of CR in our country. Objectives: The objective of this National Registry is to follow-up those existing and new CR units in Mexico through the comparison between the two previous registries, RENAPREC-2009 and RENAPREC II-2015 studies. This is a descriptive study focused on diverse CR activities such as assistance training, and certification of health professionals, barriers, reference, population attended, interdisciplinarity, permanence over time, growth prospects, regulations, post-pandemic condition, integrative characteristics, and scientific research. Results: Data were collected from 45 CR centers in the 32 states, 75.5% are private practice units, 67% are new, 33% were part of RENAPREC II-2015, and 17 have continued since 2009. With a better distribution of CR units along the territory, the median reference of candidates for CR programs is 9% with a significant reduction into tiempo of enrollment to Phase II admission (19 ± 11 days). Regarding to previous registries, the coverance of Phases I, II, and III is 71%, 100%, and 93%, respectively; and a coverance increases in evaluation, risk stratification, and prescription, more comprehensive attendance and prevention strategies. Conclusions: CR in Mexico has grown in the past 7 years. Even there is still low reference and heterogeneity in specific processes, there are strengths such as interdisciplinarity, scientific professionalization of specialists, national diversification, and an official society that are consolidated over time.

resumen está disponible en el texto completo

Reporte de caso: síndrome de absorción intravascular en histeroscopia, intoxicación por glicina / Case report: Intravascular absorption syndrome in hysteroscopy, glycine intoxication

El síndrome de absorción intravascular en histeroscopia se origina por la rápida absorción vascular de soluciones isotónicas e hipotónicas utilizadas en irrigación intrauterina, ocasionando hipervolemia y dilución de electrolitos, especialmente hiponatremia. Cuando este síndrome es debido a intoxicación por glicina al 1,5% causa acidosis severa y neurotoxicidad. La incidencia de este síndrome es baja pero puede aumentar por factores como: falta de control de altura de bolsas de irrigación, ausencia de equilibrio de fluidos de soluciones de irrigación, tejidos altamente vascularizados como miomas uterinos y uso de sistema de electrocirugía monopolar. Se reporta el caso de una paciente con miomas uterinos, programada para resección mediante histeroscopia que cursa con síndrome de absorción intravascular por glicina, el temprano diagnóstico y rápido tratamiento intraoperatorio y postoperatorio permitió una evolución favorable. El manejo se basó en el uso de diuréticos, restricción de fluidos y soluciones hipertónicas de sodio.

Intravascular absorption syndrome in hysteroscopy is caused by rapid vascular absorption of isotonic and hypotonic solutions used in intrauterine irrigation, causing hypervolemia and electrolyte dilution, especially hyponatremia. When this syndrome is due to 1.5% glycine toxicity, it causes severe acidosis and neurotoxicity. The incidence of this syndrome is low but may increase due to factors such as: lack of control of the height of irrigation bags, lack of fluid balance in irrigation solutions, highly vascularized tissues such as uterine myomas and use of a monopolar electrosurgery system. The case of a patient with uterine myomas, scheduled for resection by hysteroscopy, who presents with intravascular glycine absorption syndrome, is reported. Early diagnosis and rapid intraoperative and postoperative treatment allowed a favorable evolution. Management was based on the use of diuretics, fluid restriction, and hypertonic sodium solutions.

Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging.

BACKGROUND: Bladder cancer (BC) is among the most common cancers diagnosed in men in the USA. The current gold standards for the diagnosis of BC are invasive or lack the sensitivity to correctly identify the disease. METHODS: An aptamer-based screen analyzed the expression of 1317 proteins in BC compared to urology clinic controls. The top hits were subjected to systems biology analyses. Next, 30 urine proteins were ELISA-validated in an independent cohort of 68 subjects. Three of these proteins were next validated in an independent BC cohort of differing ethnicity. RESULTS: Systems biology analysis implicated molecular functions related to the extracellular matrix, collagen, integrin, heparin, and transmembrane tyrosine kinase signaling in BC susceptibility, with HNF4A and NFKB1 emerging as key molecular regulators. STEM analysis of the dysregulated pathways implicated a functional role for the immune system, complement, and interleukins in BC disease progression. Of 21 urine proteins that discriminated BC from urology clinic controls (UC), urine D-dimer displayed the highest accuracy (0.96) and sensitivity of 97%. Furthermore, 8 urine proteins significantly discriminated MIBC from NMIBC (AUC = 0.75-0.99), with IL-8 and IgA being the best performers. Urine IgA and fibronectin exhibited the highest specificity of 80% at fixed sensitivity for identifying advanced BC. CONCLUSIONS: Given the high sensitivity (97%) of urine D-dimer for BC, it may have a role in the initial diagnosis or detection of cancer recurrence. On the other hand, urine IL-8 and IgA may have the potential in identifying disease progression during patient follow-up. The use of these biomarkers for initial triage could have a significant impact as the current cystoscopy-based diagnostic and surveillance approach is costly and invasive when compared to a simple urine test.

Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis.

OBJECTIVE: The objective of this study was to evaluate the utility of urine CD163 for detecting disease activity in childhood-onset SLE (cSLE) patients. METHODS: Sixty consecutive pediatric patients fulfilling four or more ACR criteria for SLE and 20 healthy controls were recruited for testing of urinary CD163 using ELISA. SLE disease activity was assessed using the SLEDAI-2K. RESULTS: Urine CD163 was significantly higher in patients with active LN than inactive SLE patients and healthy controls, with receiver operating characteristics area under the curve values ranging from 0.93 to 0.96. LN was ascertained by kidney biopsy. Levels of CD163 significantly correlated with the SLEDAI, renal SLEDAI, urinary protein excretion and C3 complement levels. Urine CD163 was also associated with high renal pathology activity index and chronicity index, correlating strongly with interstitial inflammation and interstitial fibrosis based on the examination of concurrent kidney biopsies. CONCLUSION: Urine CD163 emerges as a promising marker for identifying cSLE patients with active kidney disease. Longitudinal studies are warranted to validate the clinical utility of urine CD163 in tracking kidney disease activity in children with lupus.

Setenta y cinco años de rehabilitación cardiovascular en México / Seventy-five years of cardiovascular rehabilitation in Mexico

Resumen Los pacientes que sufren una enfermedad cardiovascular requieren de atención médica integral que involucre las terapias y procedimientos necesarios para reintegrarlos de forma óptima a su vida personal, familiar, laboral y social. Las intervenciones dirigidas a alcanzar dichas metas se incluyen en los programas de rehabilitación cardiaca. Estos programas son diseáados para limitar los efectos dañinos tanto fisiológicos como psicológicos de las cardiopatías, reducir el riesgo de muerte súbita o reinfarto, controlar la sintomatología cardiovascular, estabilizar o revertir el proceso de aterosclerosis y mejorar el estado psicosocial y vocacional de los pacientes. Dichos programas existen en México desde la década de 1940 y han evolucionado a lo largo de los años, adaptándose a las condiciones de enfermedad presentes en nuestro país, desde su inicio con terapias para tratar a pacientes cardiopatía reumática hasta la aplicación del ejercicio físico en pacientes con insuficiencia cardiaca, cardiopatías congénitas complejas o hipertensión arterial pulmonar. Estas actividades son de índole transdisciplinaria e implica la integración de cardiólogos, fisioterapeutas, psicólogos y nutriólogos, entre otros. Actualmente, estos programas se han extendido a lo largo de la República Mexicana gracias a cardiólogos rehabilitadores egresados de las principales instituciones de salud del país, como son los Institutos de Salud, el IMSS (Instituto Mexicano del Seguro Social) y el ISSSTE (Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado). En este documento se expondrán los orígenes de la rehabilitación, desde la época prehispánica hasta la actual, destacando las contribuciones en docencia e investigación de los médicos que han ejercido en esta área en las instituciones previamente mencionadas.

Abstract Patients suffering from cardiovascular disease require comprehensive medical attention that involves therapies and procedures necessary to reintegrate them optimally to their personal, family, work and social life. Interventions aimed at achieving these goals are included in cardiac rehabilitation programs. These programs are designed to limit the harmful physiological and psychological effects of heart disease, reduce the risk of sudden death or reinfarction, control cardiovascular symptoms, stabilize or reverse the atherosclerosis process and improve the psychosocial and vocational status of patients. These programs have existed in Mexico since the 1940's and have evolved over the years, adapting to the disease conditions present in our country, starting with therapies to treat patients with rheumatic heart disease until the application of physical exercise in patients with heart failure, complex congenital heart disease or pulmonary arterial hypertension. These activities are of a transdisciplinary nature and involve the integration of cardiologists, physiotherapists, psychologists, and nutritionists among others. Currently, these programs have spread throughout the Mexican Republic thanks to rehabilitation cardiologists graduating from the main health institutions in the country such as Health Institutes, Mexican Social Security Institute and Institute of Security and Social Services of State Workers. In this document, the origins of rehabilitation from the pre-Hispanic era to the present will be discussed, highlighting the contributions in teaching and research of the physicians who have practiced in this area in the aforementioned institutions.

Eficacia inhibitoria del aceite esencial de Cymbopogon Citratus sobre cepas de Porphyromona Gingivalis: Estudio in vitro / Eficácia inhibitória do óleo essencial de Cymbopogon Citratus em cepas de Porphyromona Gingivalis: Estudio in vitro / Inhibitory effect of the essential oil of Cymbopogon Citratus on the strain of Porphyromona Gingivalis: In Vitro Study

Las plantas con propiedades terapéuticas utilizadas en la asistencia sanitaria tradicional han sido estudiadas ampliamente en los últimos años y constituyen una alternativa importante frente a diferentes tratamientos odontológicos.Objetivo: De-terminar el efecto inhibitorio del aceite esencial de Cymbopogon Citratus (CC) a diferentes concentraciones sobre cepas de Porphyromonas Gingivalis (Pg). Materiales y métodos: Estudio experimental, in vitro. La muestra fue constituida por 24 cajas Petri con cultivos de Pg ATCC® 33277™ en Agar Mueller Hinton, cada una con 5 discos correspondiente a los 5 grupos de estudio siendo: G1 aceite esencial de CC al 100%; G2 aceite esencial de CC al 50%; G3 aceite esencial de CC al 75%; G4 clorhexidina 0,12% (control positivo); G5 suero fisiológico (control negativo). A las 24 horas de incubación se efectúo la medición de los halos utilizando la regla Antibiotic Zone Scale (mm) con los parámetros de sensibilidad deter-minados por la escala de Duraffourd et al., 1986 siendo: Nula (-) < 8mm, Sensible (+) >8mm ≤14mm, Muy sensible (++) >14 ≤ 20mm y Sumamente sensible (+++) > 20mm. Se utilizó para el análisis los test de ANOVA y Tukey con un nivel de significancia del 5%. Resultados: El aceite esencial de CC mostró un halo de inhibición de 14mm, 12mm y 10mm a concentraciones de 100%, 50% y 75% respectivamente. La Clorhexidina 0,12% se observó valores de inhibición de 17mm. Se observó diferencia estadísticamente significativa entre los grupos (< 0.001). Conclusión: El aceite esencial de CC al 100%, 50% y 75% demostraron ser sensibles, frente a la Porphyromona Gingivalis.

Plants with therapeutic properties used in traditional healthcare have been studied in recent years and are an important alternative to different dental treatments. Objective: To determine the inhibitory effect of the essential oil of Cymbopogon Citratus (CC) at different levels on the Porphyromonas Gingivalis (Pg) strain. Materialsandmethods: Experimental study, in vitro. The sample consisted of 24 Petri dishes with cultures of Pg ATCC® 33277 ™ in Mueller Hinton Agar, each with 5 discs corresponding to the 5 study groups being: G1 essential oil of 100% CC; G2 50% CC essential oil; G3 75% CC essential oil; G4 chlorhexidine 0.12% (positive control); G5 physiological saline (negative control). At 24 hours of incubation, the halos are measured using the Antibiotic Zone Scale (mm) with the sensitivity parameters determined by the Duraffourd scale et al, 1986 being: Null (-) <8 mm, Sensitive (+) > 8 mm ≤14 mm, Very sensitive (++) > 14 ≤ 20mm and Extremely sensitive (+++)> 20mm. It was used for the ANOVA and Tukey tests analysis with a level of significance of 5%. Results: The CC essential oil showed a halo of inhibition of 14 mm, 12 mm and 10 mm at concentrations of 100%, 50% and 75% respectively. Chlorhexidine 0.12% haunted values of 17mm inhibition. There was a statistically significant difference between the groups (<0.001). Conclusion: The essential oil of CC 100%, 50% and 75% proved to be sensitive, against the Porphyromona Gingivalis.

Plantas com propriedades terapêuticas utilizadas nos cuidados se saúde tradicionais têm sido estudadas extensivamente nos últimos anos e são uma alternativa importante para diferentes tratamentos dentários. Objetivo: Determinar o efeito inibitó-rio do óleo essencial de Cymbopogon Citratus (CC) em diferentes concentrações em cepas de Porphyromonas Gingivalis(Pg). Materiais e métodos: Estudo experimental, in vitro. A amostra foi constituída por 24 placas de Petri com culturas de Pg ATCC® 33277 ™ em Ágar Mueller Hinton, cada uma com 5 discos correspondentes aos 5 grupos de estudo sendo: G1 óleo essencial de 100% CC; G2 50% de óleo essencial de CC; G3 75% de óleo essencial de CC; Clorexidina G4 0,12% (controle positivo); G5 soro fisiológico (controle negativo). Após 24 horas de incubação a medição dos halos foi realizada utilizando a regra Antibiotic Zone Scale (mm) com parâmetros de sensibilidade determinados pela escala de Duraffourd et al, 1986 sendo: nulo. (-) <8 milímetros, sensível (+ )> 8mm ≤14mm, Muito sensível (++)> 14 ≤ 20mm e Extremamen-te sensível (+++)> 20mm. Os testes ANOVA e Tukey com nível de significância de 5% foram utilizados para a análise. Resultados: O óleo essencial de CC apresentou halo de inibição de 14mm, 12mm e 10mm nas concentrações de 100%, 50% e 75%, respectivamente. Valores de inibição de clorexidina 0,12% de 17mm foram observados. Observamos diferença estatisticamente significante entre os grupos (<0,001). Conclusão: O óleo essencial de 100% CC, 50% e 75% mostrou-se sensível, contra o Porphyromona Gingivalis.

Association between premature ventricular complexes during exercise, long-term occurrence of life-threatening arrhythmia and mortality / Asociación entre ectopia ventricular en ejercicio, la ocurrencia de arritmias potencialmente mortales y mortalidad a largo plazo

Abstract Objective: Exercise-induced premature ventricular complexes (EiPVCs) are often considered as benign arrhythmias, although they are associated with a high risk of all-cause death in the general healthy population. However, an intermediate pathophysiological process remains unclear, particularly in patients with known cardiovascular disease. The aim of this study was to find an association between EiPVCs, the occurrence of life-threatening ventricular arrhythmias (LACO), and all-cause mortality in patients with cardiovascular disease. Methods: This was an observational study of a cohort of patients with coronary artery disease (CAD) or idiopathic cardiomyopathy (ICM). Stress testing was performed as a part of the routine cardiovascular evaluation. The occurrence of EiPVCs was evaluated during exercise testing (ET). At follow-up, long-term occurrence of LACO was evaluated. A bivariate and multivariate analysis was performed. Results: Out of the total of 1442 patients analysed, 700 (49%) had EiPVCs. During 14 years of following-up after ET, 106 LACO outcomes were observed. Long-term all-cause mortality was 4% (n = 61). A bivariate analysis showed that patients with EiPVCs had an increased risk for LACO (RR = 2.81, 95% CI; 1.9---4.3, P < .001), and for mortality (RR = 2.1, CI95% 1.2---3.4, P < .01). Occurrence of LACO was also associated with a higher mortality risk (RR = 5.7, 95% CI; 3.4---9.4, P < .001). After a post hoc analysis, LACO remained as a highly predictive variable for mortality. Conclusion: Patients with EiPVCs have a high risk of LACO and all-cause mortality. The presence of LACO could be an intermediate stage between EiPVCs and mortality in subjects with cardiovascular disease.

Resumen Objetivo: La extrasistolia ventricular inducida por ejercicio (EVIE) suele considerarse una arritmia benigna, sin embargo, ha sido asociada a mayor mortalidad en población general. Hasta hoy no se ha encontrado el proceso fisiopatológico involucrado, particularmente en pacientes con enfermedad cardiovascular. El objetivo del estudio fue establecer una asociación entre EVIE con la ocurrencia de arritmias ventriculares potencialmente malignas (APM) y letalidad a largo plazo, en sujetos con enfermedad cardiovascular. Método: Estudiamos una cohorte de pacientes con enfermedad coronaria o miocardiopatía dilatada, que realizaron una prueba de ejercicio al inicio del estudio. Inicialmente evaluamos la ocurrencia de EVIE, APM y letalidad a largo plazo y posteriormente se realizó un estudio bivariable y multivariable. Resultados: Se incluyeron 1,442 pacientes de los cuales 700 presentaron EVIE (49%). Durante 14 an˜os de seguimiento, 106 sujetos presentaron APM y la mortalidad total fue de 61 casos (4%). El estudio bivariable mostró que aquellos pacientes con EVIE tuvieron un riesgo de presentar APM de 2.81 (IC95% de 1.9 a 4.3, p < 0.001) y de mortalidad de 2.1 (IC95% de 1.2 a 3.4, p < 0.01). Los individuos con APM tuvieron mayor riesgo de mortalidad (RR= 5.7, IC95% de 3.4 a 9.4, p < 0.001). Después de un análisis multivariable, la APM continuó siendo una variable altamente predictiva de mortalidad. Conclusión: Los pacientes con EVIE tienen un riesgo elevado de presentar APM y de mortalidad a largo plazo. Los resultados sugieren que las APM podrían representar un estado intermedio entre la presencia de EVIE y la mortalidad en pacientes con enfermedad cardiovascular.

National Registry of Cardiac Rehabilitation Programs in Mexico II (RENAPREC II) / Registro Nacional de Programas de Rehabilitación Cardiaca en México II (RENAPREC II)

Abstract: Objective: The aim of this paper is to compare the state of Cardiac Rehabilitation Programs (CRP) in 2009 with 2015. Focus is directed on health care, training of health-providers, research, and the barriers to their implementation. Methods: All authors of RENAPREC-2009, and other cardiac rehabilitation leaders in Mexico were requested to participate. These centres were distributed into two groups: RENAPREC-2009 centres that participated in 2015, and the new CRP units. Results: In 2009 there were 14 centres, two of which disappeared and another two did not respond. CRP-units increased by 71% (n = 24), and their geographic distribution shows a centripetal pattern. The coverage of CRP-units was 0.02 centres per 100,000 inhabitants. Only 4.4% of eligible patients were referred to CRP, with a rate of 10.4 patients/100,000 inhabitants in 2015. The ratio of Clinical Cardiologists to Cardiac Rehabilitation Specialists was 94:1, and the ratio of Intervention Specialists to cardiac rehabilitation experts was 16:1. Cardiac rehabilitation activities and costs varied widely. Patient dropout rate in phase II was 12%. Several barriers were identified: financial crisis (83%), lack of skilled personnel (67%), deficient equipment (46%), inadequate areas (42%), and a reduced number of operating centres (38%). Conclusions: CRPs in Mexico are still in the process of maturing. Mexican CRP-centres have several strengths, like the quality of the education of the professionals and the multidisciplinary programs. However, the lack of referral of patients and the heterogeneity of procedures are still their main weaknesses.

Resumen: Objetivo: El propósito de este trabajo es comparar el estado actual de los programas de rehabilitación cardiaca (PRC) en México con el RENAPREC-2009, dirigido a la asistencia, docencia, investigación y barreras. Métodos: Se convocó a participar a todos los autores de RENAPREC-2009 y a otros líderes en rehabilitación cardiaca de México. Los centros fueron distribuidos en 2 grupos: los que participaron en el 2015 y las nuevas unidades de PRC. Resultados: En 2009 había 14 centros operativos, de los cuales 2 cerraron y 2 no respondieron. En 2015 se registraron 24 centros en total, representando un aumento neto del 71%. La distribución geográfica fue centrípeta. La cobertura fue de 0.02 centros/100,000 habitantes y de solamente un 4.4% de los pacientes elegibles (10.4 pacientes/100,000 habitantes). La relación cardiólogo clínico-rehabilitador cardiaco es de 94:1 y la de intervencionista-rehabilitador cardiaco es de 16:1. Las actividades realizadas y los costos de los PRC varían de forma importante de centro a centro. En promedio, el 12% de los pacientes en fase ii abandonaron el programa. Las principales barreras para el desarrollo de PRC fueron: económicas (83%), falta de personal capacitado (67%), falta de equipo (46%), áreas inadecuadas (42%) y un insuficiente número de centros operativos (38%). Conclusiones: Los PRC en nuestro país continúan en crecimiento. Se observan fortalezas como el nivel de docencia y el enfoque multidisciplinario, así como deficiencias en la homogeneidad de las actividades y la falta de referencia de la población elegible.

Non-Traumatic Spontaneous Spinal Subdural Hematoma in a Patient with Non-Valvular Atrial Fibrillation During Treatment with Rivaroxaban.

BACKGROUND: Spontaneous spinal subdural hematoma (SSDH) is a rare but disabling condition, accounting for only 4.1% of all intraspinal hematomas. Risk factors include arteriovenous malformations, coagulopathy, therapeutic anticoagulation, underlying neoplasms, or following spinal puncture. Vitamin K antagonists, antiplatelet agents, and heparinoids have been associated with SSDHs in prior reports. To the best of our knowledge, no cases have reported this association with the factor Xa inhibitor, rivaroxaban, and SSDHs. CASE REPORT: We report the case of a 69-year-old Honduran man with a 5-year history of symptomatic palpitations due to non-valvular atrial fibrillation. He was initially refractory to pharmacologic therapy. He underwent cardioversion in February 2014. After cardioversion, he remained asymptomatic on flecainide. He was anticoagulated on rivaroxaban 20 mg daily without incident since early 2013 until presentation in August 2014. He presented with sudden onset of excruciating upper and lower back pain after minimal movement. This was immediately followed by bilateral lower extremity paresis rapidly progressing to paraplegia with bowel and bladder dysfunction over 15 minutes. Magnetic resonance imaging demonstrated an acute spinal subdural hematoma extending from T3 inferiorly to the conus medullaris. Six months after undergoing cervical and lumbar drainage procedures, he has not recovered bowel, bladder, or lower extremity neurologic function. CONCLUSIONS: Non-traumatic spontaneous spinal subdural hematoma is a rare neurological emergency that may occur during the use of rivaroxaban in patients with non-valvular atrial fibrillation. Physicians should suspect SSDH in patients on rivaroxaban with acute onset of severe back pain and neurologic symptoms to improve the odds of a favorable outcome.

Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease.

OBJECTIVES: This study evaluated the regulation and function of micro-RNAs (miRs) in bone marrow-mononuclear cells (BMCs). BACKGROUND: Although cell therapy with BMCs may represent a therapeutic option to treat patients with heart disease, the impaired functionality of patient-derived cells remains a major challenge. Small noncoding miRs post-transcriptionally control gene expression patterns and play crucial roles in modulating cell survival and function. METHODS: Micro-RNAs were detected by miR profiling in BMCs isolated from healthy volunteers (n = 6) or from patients with myocardial infarction (n = 6), and the results were confirmed by polymerase chain reaction (PCR) in a larger cohort (n = 37). The function of selected miRs was determined by gain-of-function studies in vitro and by locked nuclear acid (LNA) modified inhibitors in vitro and in vivo. RESULTS: We identified several miRs that are up-regulated in BMCs from patients with myocardial infarction compared with BMCs from healthy controls, including the pro-apoptotic and antiproliferative miR-34a and the hypoxia-controlled miR-210. Inhibition of miR-34 by LNA-34a significantly reduced miR-34a expression and blocked hydrogen peroxide-induced cell death of BMC in vitro, whereas overexpression of miR-34a reduced the survival of BMCs in vitro. Pre-treatment of BMCs with LNA-34a ex vivo significantly increased the therapeutic benefit of transplanted BMCs in mice after acute myocardial infarction (AMI). CONCLUSIONS: These results demonstrate that cardiovascular disease modulates the miR expression of BMCs in humans. Reducing the expression of the pro-apoptotic miR-34a improves the survival of BMCs in vitro and enhances the therapeutic benefit of cell therapy in mice after AMI.